Can Comprehensive Lifestyle Change Alter the Course of Chronic Kidney Disease?

Seminars in Nephrology

Volumn 29, Issue 5, 2009, Pages 512-523

  Tuttle, Katherine R ^a,b   Sunwold, Duane ^c   Kramer, Holly ^d  

^a SACRED HEART MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Spokane Community College   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dietary protein; exercise; macronutrients; obesity; sodium

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBOHYDRATE; FAT; PROTEIN; SODIUM;

ALCOHOL CONSUMPTION; ARTICLE; CALORIC RESTRICTION; CARBOHYDRATE DIET; CHRONIC KIDNEY DISEASE; DISEASE COURSE; EVIDENCE BASED MEDICINE; EXERCISE; FAT INTAKE; FOOD COMPOSITION; HEALTH BEHAVIOR; HEALTH PROMOTION; HEMODYNAMICS; HUMAN; LIFESTYLE MODIFICATION; MACRONUTRIENT; OBESITY; OVERNUTRITION; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN INTAKE; PROTEIN RESTRICTION; QUALITY OF LIFE; RENAL PROTECTION; SMOKING; WEIGHT CONTROL;

ALCOHOL DRINKING; ENERGY INTAKE; EXERCISE; HUMANS; KIDNEY FAILURE, CHRONIC; LIFE STYLE; OBESITY; SMOKING; SODIUM, DIETARY;

EID: 69949185593     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2009.06.008     Document Type: Article

References (89)

1. Brenner B.M., Meyer T.W., and Hostetter T.H. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307 (1982) 652-659
2. Hostetter T.H., Meyer T.W., Rennke H.G., and Brenner B.M. Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int 30 (1986) 509-517
3. Zatz R., Meyer T.W., Rennke H.G., and Brenner B.M. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A 82 (1985) 5963-5967
4. Tuttle K.R., Bruton J.L., Perusek M.C., Lancaster J.L., Kopp D.T., and DeFronzo R.A. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 324 (1991) 1626-1632
5. Tuttle K.R., and Bruton J.L. Effect of insulin therapy on renal hemodynamic response to amino acids and renal hypertrophy in non-insulin-dependent diabetes. Kidney Int 42 (1992) 167-173
6. Tuttle K.R., Puhlman M.E., Cooney S.K., and Short R.A. Effects of amino acids and glucagon on renal hemodynamics in type 1 diabetes. Am J Physiol Renal Physiol 282 (2002) F103-F112
7. Uribarri J., and Tuttle K.R. Advanced glycation end products and nephrotoxicity of high protein diets. Clin J Am Soc Nephrol 1 (2006) 1293-1299
8. Finot P.A. Historical perspective of the Maillard reaction in food science. Ann N Y Acad Sci 1043 (2005) 1-8
9. Anderson M.M., Requena J.R., Crowley J.R., Thorpe S.R., and Heinecke J.W. The myeloperoxidase system of human phagocytes generates N epsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 104 (1999) 103-113
10. Anderson M.M., and Heinecke J.W. Production of N epsilon-(carboxymethyl)lysine is impaired in mice deficient in NADPH oxidase. A role for phagocyte-derived oxidants in the formation of advanced glycation end products during inflammation. Diabetes 52 (2003) 2137-2143
11. Silbiger S., Crowley S., Shan Z., Brownlee M., Satriano J., and Schlondorff D. Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge. Kidney Int 43 (1993) 853-864
12. Mott J.D., Khalifah R.G., Nagase H., Shield III C.F., Hudson J.K., and Hudson B.G. Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. Kidney Int 52 (1997) 1302-1312
13. Krishnamurti U., Rondeau E., Sraer J.D., Michael A.F., and Tsilibary E.C. Alterations in human glomerular epithelial cells interacting with nonenzymatically glycosylated matrix. J Biol Chem 272 (1997) 27966-27970
14. Charonis A.S., and Tsilbary E.C. Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes 41 (1992) S49-S51
15. Lee H.B., Yu M.R., Yang Y., Jiang Z., and Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14 (2003) S241-S245
16. Zhou G., Li C., and Cai L. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am J Pathol 165 (2004) 2033-2043
17. Huang J.S., Guh J.Y., Chen H.C., Hung W.C., Lai Y.H., and Chuang L.Y. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J Cell Biochem 81 (2001) 102-113
18. Twigg S.M., Cao Z., McLennan S.V., Burns W.C., Brammar G., Forbes J.M., et al. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 143 (2002) 4907-4915
19. Goldberg T., Cai W., Peppa M., Dardaine V., Baliga B.S., Uribarri J., et al. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 104 (2004) 1287-1291
20. Uribarri J., Cai W., Sandu O., Peppa M., Goldberg T., and Vlassara H. Diet-derived glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci 1043 (2005) 461-466
21. Tuttle K.R., Johnson E.C., Cooney S.K., Anderberg R.J., Johnson E.K., Clifton G.D., et al. Amino acids injure mesangial cells by advanced glycation end products, oxidative stress, and protein kinase C. Kidney Int 67 (2005) 953-968
22. Tuttle K.R., Anderberg R., Cooney S., and Meek R. Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet. Am J Nephrol 29 (2009) 171-180
23. Cai W., Gao Q.D., Zhu L., Peppa M., He C.J., and Vlassara H. Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol Med 8 (2002) 337-346
24. Cai W., He J.C., Zhu L., Peppa M., Lu C., Uribarri J., et al. High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients. Circulation 110 (2004) 285-291
25. Vlassara H., Cai W., Crandall J., Goldberg T., Oberstein R., Dardaine V., et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A 99 (2002) 15596-15601
26. Uribarri J., Peppa M., Cai W., Goldberg T., Lu M., He C., et al. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol 14 (2003) 728-731
27. Peppa M., Uribarri J., Cai W., Lu M., and Vlassara H. Glycoxidation and inflammation in renal failure patients. Am J Kidney Dis 43 (2004) 690-695
28. Tanji N., Markowitz G.S., Fu C., Kislinger T., Taguchi A., Pischetsrieder M., et al. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol 11 (2000) 1656-1666
29. Wrone E.M., Carnethon M.R., Palaniappan L., and Fortmann S.P. Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 580-587
30. Knight E.L., Stampfer M.J., Hankinson S.E., Spiegelman D., and Curhan G.C. The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med 138 (2003) 460-467
31. Hoogeveen E.K., Kostense P.J., Jager A., Heine R.J., Jakobs C., Bouter L.M., et al. Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int 54 (1998) 203-209
32. Bernstein A.M., Treyzon L., and Zhaoping L. Are high-protein diet, vegetable-based diets safe for kidney function?. A review of the literature. J Am Diet Assoc 17 (2007) 644-650
33. Foster G.D., Wyatt H.R., Hill J.O., McGuckin B.G., Brill C., Mohammed B.S., et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 348 (2003) 2082-2090
34. Yancy Jr. W.S., Olsen M.K., Guyton J.R., Bakst R.P., and Westman E.C. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med 140 (2004) 769-777
35. Brehm B.J., Seeley R.J., Daniels S.R., and D'Alessio D.A. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab 88 (2003) 1617-1623
36. Stern L., Iqbal N., Seshadri P., Chicano K.L., Daily D.A., McGrory J., et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med 140 (2004) 778-785
37. Pedrini M.T., Levey A.S., Lau J., Chalmers T.C., and Wang P.H. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med 124 (1996) 627-632
38. Kasiske B.L., Lakatua J.D., Ma J.Z., and Louis T.A. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 31 (1998) 954-961
39. Pan Y., Guo L.L., and Hui M.J. Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88 (2008) 660-666
40. Fouque D., Laville M., Boissel J.P., Chifflet R., Labeeuw M., and Zech P.Y. Controlled low protein diets in chronic renal insufficiency: meta-analysis. BMJ 304 (1992) 216-220
41. Fouque D., Wang P., Laville M., and Boissel J.P. Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure. Nephrol Dial Transplant 15 (2000) 1986-1992
42. Fouque D., Laville M., and Boissel J.P. Low protein diets for chronic kidney disease in non-diabetic adults. Cochrane Database Syst Rev 2 (2006) CD001892
43. Klahr S., Levey A.S., Beck G.J., Caggiula A.W., Hunsicker L., Kusek J.W., et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group. N Engl J Med 330 (1994) 877-884
44. Levey A.S., Greene T., Beck G.J., Caggiula A.W., Kusek J.W., Hunsicker L.G., et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown?. Modification of diet in renal disease study group. J Am Soc Nephrol 10 (1999) 2426-2439
45. Hansen H.P., Tauber-Lassen E., Jensen B.R., and Parving H.H. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 62 (2002) 220-228
46. Dietary intake of ten key nutrients for public health, United States: 1999-2000. Advance data report no. 334. www.cdc.gov/nchs/data/ad/ad334.pdf [cited 2008 December]
47. National Academy of Sciences, Institute of Medicine. Dietary reference intakes for energy, carbohydrates, fiber, fat, fatty acids, cholesterol, protein and amino acids (Macronutrients). Chapter 8 (2002), The National Academy Press, Washington, DC
48. American Diabetes Association. ADA standards of medical care in diabetes-2008. Diabetes Care 31 (2008) S20-S21
49. American Heart Association. Step I, step II, and TLC diets. [cited 2008 December] (2008). http://www.americanheart.org/presenter.jhtml?identifier=4764
50. Hamazaki T., Takazakura E., Osawa K., Urakaze M., and Yano S. Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester. Lipids 9 (1990) 541-545
51. Dullart R.P., Beusekamp B.J., Meijer S., Hoogenberg K., van Doormaal J.J., and Sluiter W.J. Long-term effects of linoleic-acid-enriched diet on albuminuria and lipid levels in type 1 (insulin-dependent) diabetic patients with elevated urinary albumin excretion. Diabetologia 35 (1992) 165-172
52. Bouhanick B., Suraniti S., Berrut G., Bled F., Simard G., Lejeune J.J., et al. Relationship between fat intake and glomerular filtration rate in normotensive insulin-dependent diabetic patients. Diabetes Metab 21 (1995) 168-172
53. Rossing P., Hansen B.V., Nielsen F.S., Myup B., Holmer G., and Parving H.H. Fish oil in diabetic nephropathy. Diabetes Care 19 (1996) 1214-1219
54. Mollsten A., Dahlquist G., Stattin E.-L., and Rudberg S. Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type 1 diabetic patients. Diabetes Care 24 (2001) 805-811
55. National Kidney Foundation. KDOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45 Suppl 3 (2005) S90-S95
56. Kris-Etherton P., William H., and Appel L. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
57. Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344 (2001) 3-10
58. He J., Gu D., Wu X., Chen J., Duan X., Chen J., et al. Effect of soybean protein on blood pressure: a randomized, controlled trial. Ann Intern Med 143 (2005) 1-9
59. Appel L.J., Sacks F.M., Carey V.J., Obarzanek E., Swain J.F., Miller III E.R., et al., OmniHeart Collaborative Research Group. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 294 (2005) 2455-2464
60. Azadbakht L., Shakerhosseini R., Atabak S., Jamshidian M., Mehrabi Y., and Esmaill-Zadeh A. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr 57 (2003) 1292-1294
61. Pecis M., Azevedo M., and Gross J. Chicken and fish diet reduces glomerular hyperfiltration in IDDM patients. Diabetes Care 17 (1994) 665-672
62. Jibani M.M., Bloodworth L.L., Foden E., Griffiths K.D., and Galpin O.P. Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: effects on albumin excretion rate and nutritional status. Diabetic Med 8 (1991) 949-953
63. Cutler J.A., and Obarzanek E. Nutrition and blood pressure: is protein one link?. Toward a strategy of hypertension prevention. Ann Intern Med 143 (2005) 74-75
64. Flegal K.M., Graubard B.I., Williamson D.F., and Gail M.H. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298 (2007) 2028-2037
65. Wang Y., Chen X., Song Y., Caballero B., and Cheskin L.J. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 73 (2007) 19-33
66. Muntner P., Winston J., Uribarri J., Mann D., and Fox C.S. Overweight, obesity, and elevated cystatin C levels in adults in the United States. Am J Med 121 (2008) 341-348
67. Hsu C.-Y., McCulloch C.E., Iribarren C., Darbinian J., and Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 21-28
68. World Health Organization (WHO). Obesity: preventing and managing the global epidemic: report of a WHO consultation on obesity, Geneva, June 3-5, 1997 (1998), World Health Organization, Geneva
69. Elsayed E.F., Tighiouart H., Weiner D.E., Griffith J., Salem D., Levey A.S., et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis 52 (2008) 49-57
70. Griffin K.A., Kramer H., and Bidani A.K. Adverse renal consequences of obesity. Am J Physiol Renal Phys 294 (2008) F685-F696
71. Poirier P., Giles T.D., Bray G.A., Hong Y., Stern J.S., Pi-Sunyer F.X., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113 (2006) 898-918
72. Orchard T.J., Temprosa M., Goldberg R., Haffner S., Ratner R., Marcovina S., et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 142 (2005) 611-619
73. Morales E., Valero M.A., Leon M., Hernandez E., and Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 41 (2003) 319-327
74. Anonymous. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Guideline 5: nutritional management in diabetes and chronic kidney disease. Am J Kidney Dis 49 (2007) S95-S107
75. Kramer H., Tuttle K.R., Leehey D., Luke A., Durazo-Arvizu R., Shoham D., et al. Obesity management in adults with chronic kidney disease. Am J Kidney Dis 53 (2009) 151-165
76. Snow V., Barry P., Fitterman N., Qaseem A., and Weiss K. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians. Ann Intern Med 142 (2005) 525-531
77. Chen J., Muntner P., Hamm L.L., Batuman V., Fonseca V., Whelton P.K., et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14 (2003) 469-477
78. Chen J., Muntner P., Hamm L.L., Jones D.W., Batuman V., Fonseca V., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140 (2004) 167-174
79. Bagby S.P. Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?. J Am Soc Nephrol 15 (2004) 2775-2791
80. Tuttle K.R. Renal manifestations of the metabolic syndrome. Nephrol Dial Transplant 20 (2005) 861-864
81. Packard D.P., Milton J.E., Shuler L.A., Short R.A., and Tuttle K.R. Implications of chronic kidney disease for dietary treatment of cardiovascular disease. J Renal Nutr 16 (2006) 259-268
82. Eckel R.H. Clinical practice. Nonsurgical management of obesity in adults. N Engl J Med 358 (2008) 1941-1950
83. Venkataraman R., Sanderson B., and Bittner V. Outcomes in patients with chronic kidney disease undergoing cardiac rehabilitation. Am Heart J 150 (2005) 1140-1146
84. Heiwe S., Clyne N., Tollback A., and Borg K. Effects of regular resistance training on muscle histopathology and morphometry in elderly patients with chronic kidney disease. Am J Phys Med Rehabil 84 (2005) 865-874
85. Moinuddin I., and Leehey D.J. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease. Adv Chronic Kidney Dis 15 (2008) 83-96
86. Chuahirun T., and Wesson D.E. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite angiotensin converting enzyme inhibition. Am J Kidney Dis 39 (2002) 376-382
87. Phisitkul K., Hegazy K., Chuahirun T., Hudson C., Simoni J., Rajab H., et al. Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy. Am J Med Sci 335 (2008) 284-291
88. Schaeffner E.S., Kurth T., de Jong P.E., Glynn R.J., Buring J.E., and Gaziano M. Alcohol consumption and the risk of renal dysfunction in apparently healthy men. Arch Intern Med 165 (2005) 1048-1053
89. Knight E.L., Stampfer M.J., Rimm E.B., Hankinson S.E., and Curhan G.C. Moderate alcohol intake and renal function decline in women: a prospective study. Nephrol Dial Transplant 18 (2003) 1549-1554